Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

Nature

Volumn 447, Issue 7147, 2007, Pages 959-965

  Furuhashi, Masato ^a   Tuncman, Gürol ^a   Görgün, Cem Z ^a   Makowski, Liza ^a,d   Atsumi, Genichi ^a,e   Vaillancourt, Eric ^a   Kono, Keita ^a   Babaev, Vladimir R ^b   Fazio, Sergio ^b   Linton, MacRae F ^b   Sulsky, Richard ^c   Robl, Jeffrey A ^c   Parker, Rex A ^c   Hotamisligil, Gökhan S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 309403; FATTY ACID BINDING PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DIABETES; DISEASE TREATMENT; FATTY ACID; INHIBITION; METABOLISM; MODELING; PROTEIN; RODENT;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; DRUG EFFECT; DRUG SCREENING; MACROPHAGE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MUS;

EID: 34250904186     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05844     Document Type: Article

References (28)

1. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
2. Hertzel, A. V. & Bernlohr, D. A. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol. Metab. 11, 175-180 (2000).
3. Hunt, C. R., Ro, J. H., Dobson, D. E., Min, H. Y. & Spiegelman, B. M. Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc. Natl Acad. Sci. USA 83, 3786-3790 (1986).
4. Melki, S. A. & Abumrad, N. A. Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation. J. Lipid Res. 34, 1527-1534 (1993).
5. Distel, R. J., Robinson, G. S. & Spiegelman, B. M. Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms. J. Biol. Chem. 267, 5937-5941 (1992).
6. Hotamisligil, G. S. et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274, 1377-1379 (1996).
7. Uysal, K. T., Scheja, L., Wiesbrock, S. M., Bonner-Weir, S. & Hotamisligil, G. S. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141, 3388-3396 (2000).
8. -/- mice. Diabetes 48, 1987-1994 (1999).
9. Makowski, L. et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Med. 7, 699-705 (2001).
10. Kazemi, M. R., McDonald, C. M., Shigenaga, J. K., Grunfeld, C. & Feingold, K. R. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler. Thromb. Vasc. Biol. 25, 1220-1224 (2005).
11. Fu, Y., Luo, N. & Lopes-Virella, M. F. Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J. Lipid Res. 41, 2017-2023 (2000).
12. Pelton, P. D., Zhou, L., Demarest, K. T. & Burris, T. P. PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem. Biophys. Res. Commun. 261, 456-458 (1999).
13. Boord, J. B. et al. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 22, 1686-1691 (2002).
14. Sulsky, R. et al. Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorg. Med. Chem. Lett. (in the press)
15. Makowski, L., Brittingham, K. C., Reynolds, J. M., Suttles, J. & Hotamisligil, G. S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities. J. Biol. Chem. 280, 12888-12895 (2005).
16. Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002).
17. Tuncman, G. et al. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl Acad. Sci. USA 103, 10741-10746 (2006).
18. Maeda, K. et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 1, 107-119 (2005).
19. Cao, H. et al. Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice. Diabetes 55, 1915-1922 (2006).
20. Llaverias, G. et al. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem. Biophys. Res. Commun. 318, 265-274 (2004).
21. Fu, Y., Luo, N., Lopes-Virella, M. F. & Garvey, W. T. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 165, 259-269 (2002).
22. Fisher, R. M. et al. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 44, 1268-1273 (2001).
23. Tuncman, G. et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc. Natl Acad. Sci. USA 103, 6970-6975 (2006).
24. Sethi, J. K. et al. Characterisation of receptor-specific TNFα functions in adipocyte cell lines lacking type 1 and 2 TNF receptors. FEBS Lett. 469, 77-82 (2000).
25. Babaev, V. R., Patel, M. B., Semenkovich, C. F., Fazio, S.&Linton, M. F. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J. Biol. Chem. 275, 26293-26299 (2000).
26. Kim, J. K. et al. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J. Clin. Invest. 105, 1791-1797 (2000).
27. Blasi, E. et al. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature 318, 667-670 (1985).
28. Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917 (1959).